DAMORA THERAPEUTICS, INC. Deferred Tax Assets, Property, Plant and Equipment
DAMORA THERAPEUTICS, INC. (DMRA) had Deferred Tax Assets, Property, Plant and Equipment of $4.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Property, Plant and Equipment $4.00K.
- 2024-12-31: Deferred Tax Assets, Property, Plant and Equipment $9.00K.
- 2023-12-31: Deferred Tax Assets, Property, Plant and Equipment $16.00K.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $4.00K 10-K · filed 2026-03-19 |
| 2024-12-31 | $9.00K 10-K · filed 2026-03-19 |
| 2023-12-31 | $16.00K 10-K · filed 2025-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |